The Skin Hospital is proud to have been nominated as a finalists for the Global 2020 Site Patient Recruitment Innovation Award.
The Skin Hospital has over 10 years of experience in the management of clinical trials. As patient safety is our main priority, all our clinical trials are thoroughly reviewed and approved by an external ethics committee.
Our dedicated team are experts in conducting dermatological clinical trials, from Phase I through to Phase IV, including pharmaceutical and device trials. Their extensive experience and commitment to each trial allows for the collection of valuable research, furthering the development of potential treatments for various skin conditions.
Our state-of-the-art facilities include exclusive clinical consultation rooms, across our Darlinghurst and Westmead hospitals. All members of our clinical trials team are focused on ensuring the best service and results for participants.
Active Clinical Trials
Currently Recruiting:
Spontaneous Chronic Urticaria for Adults
A randomised, placebo-controlled, double-blind study to assess the efficacy and safety of a new investigational product in patients with Chronic Spontaneous Urticaria (CSU) in participants aged 18 years and older.
We are seeking adult participants for this new clinical trial.
Ulcerative Pyoderma Gangrenosum for adults
A randomised, placebo-controlled, double-blind trial to evaluate the safety and efficacy of new therapy in adult patients with a rare skin condition known as ulcerative pyoderma gangrenosum (PG).
We are seeking adult participants for this new clinical trial.
Find out more about this clinical trial by clicking below.
Hidradenitis Suppurativa (HS) for adults
A randomised, double-blind, placebo-controlled study assessing the efficacy, safety, and tolerability of a potential new treatment in adult patients with hidradenitis suppurativa (HS).
We are seeking adult participants for this new clinical trial.
Find out more about this clinical trial by clicking below.
Atopic Dermatitis Study for Adolescents
An Open-Label multinational, multicenter study to evaluate the long-term safety, tolerability, and efficacy of a new experimental treatment in participants aged 12-17 years with moderate to severe atopic dermatitis.
We are seeking adolescent participants for this new clinical trial.
Find out more about this clinical trial by clicking below.
Active Clinical Trials
Recruitment Paused:
Active Clinical Trials
No Longer Recruiting:
Vitiligo Study for Adults and Adolescents (12 Years and Older)
This study aims to explore if experimental tablets is an effective treatment for vitiligo spots.
Alopecia Areata Study for Adults (18 years and older)
This phase 2 study aims to evaluate the efficacy and safety of an experimental medication in patients with severe alopecia areata.
Hand Eczema Study for Adolescents (12 – 17 Years)
This study aims to investigate if an experimental cream medication is an effective treatment for moderate-severe chronic hand eczema.
Plaque Psoriasis Study for Adults (18 years and older)
This phase 4 study aims to investigate if an experimental medication is as effective as a currently used treatment for moderate plaque psoriasis.